Sign in

CIK 0001817229

  • Emerging growth company

Vor Biopharma Inc.

Sign in to watch
Ticker
VOR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
811591163
Phone
+1 617-655-6580
Business address
500 BOYLSTON STREET, SUITE 1350, BOSTON, MA, 02116
  1. 4 Derivatives Options or other derivatives
  2. 4 Open-market sale 10% owner sold 330,706 shares at $15.30 ($5,059,802)
  3. 4 Open-market sale Director sold 330,706 shares at $15.30 ($5,059,802)
  4. 4 Option exercise Chief Scientific Officer acquired 17,446 shares (option exercise)
  5. 4 Other acquisition Director acquired 998,382 shares (other)
  6. 4 Conversion 10% owner acquired 282,804 shares (conversion)
  7. 4 Open-market buy Director bought 2,979,566 shares at $18.00 ($53,632,188)
  8. 4 Open-market buy 10% owner bought 555,555 shares at $18.00 ($9,999,990)
  9. 4 Conversion Chief Financial Officer acquired 3,534 shares (conversion)
  10. 4 Conversion Chief Scientific Officer acquired 3,534 shares (conversion)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Open-market buy Director bought 555,555 shares at $18.00 ($9,999,990)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 10 of 11 · 212 filings